Clinical Trial Update: The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination

View source ↗

Summary

This study investigates the expression of OX40 (CD134) in sarcoma specimens and evaluates its potential use in determining prognosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Snippet

Sponsor: Peking University People's Hospital | Conditions: Sarcoma, Biomarkers | Status: ACTIVE_NOT_RECRUITING